Home Amines 2963-77-1
2963-77-1,MFCD00454395
Catalog No.:AA002YVD

2963-77-1 | 4-(1H-Benzoimidazol-2-yl)-phenylamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$46.00   $32.00
- +
1g
95%
in stock  
$78.00   $55.00
- +
5g
95%
in stock  
$256.00   $179.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002YVD
Chemical Name:
4-(1H-Benzoimidazol-2-yl)-phenylamine
CAS Number:
2963-77-1
Molecular Formula:
C13H11N3
Molecular Weight:
209.2465
MDL Number:
MFCD00454395
SMILES:
Nc1ccc(cc1)c1nc2c([nH]1)cccc2
NSC Number:
403411
Properties
Properties
 
BP:
466.3°C at 760 mmHg  
Form:
Solid  
MP:
248.0 to 252.0 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
235  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
2.6  

Upstream Synthesis Route

[1]ChemicalandPharmaceuticalBulletin,2007,vol.55,#1,p.115-117

[2]ChineseChemicalLetters,2011,vol.22,#3,p.296-299

[3]EuropeanJournalofMedicinalChemistry,2017,vol.126,p.24-35

[4]EuropeanJournalofMedicinalChemistry,2016,vol.117,p.59-69

[5]JournaloftheChileanChemicalSociety,2012,vol.57,#2,p.1122-1125,4

[6]JournalofOrganicChemistry,1987,vol.52,#22,p.5009-5015

[7]BioorganicandMedicinalChemistry,2014,vol.22,#21,p.5970-5987

[8]JournalofMedicinalChemistry,1996,vol.39,#17,p.3375-3384

[9]MedicinalChemistryResearch,2017,vol.26,#11,p.3026-3037

[10]EuropeanJournalofMedicinalChemistry,2018,vol.159,p.243-254

[11]JournalofHeterocyclicChemistry,1990,vol.27,#5,p.1177-1180

[12]BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.404-408

[13]TurkishJournalofChemistry,2018,vol.42,#3,p.896-907

[14]Patent:WO2005/42496,2005,A1,.Locationinpatent:Page/Pagecolumn29

[15]MedicinalChemistry,2014,vol.10,#4,p.418-425

[16]ZhurnalObshcheiKhimii,1955,vol.25,p.2138,2140;engl.Ausg.S.2097,2099

[17]JournalofMedicinalChemistry,1999,vol.42,#3,p.381-392

[18]BioorganicandMedicinalChemistryLetters,2006,vol.16,#2,p.409-412

[19]Patent:US5633388,1997,A,

[20]MedicinalChemistryResearch,2013,vol.22,#6,p.2840-2846

[21]BioorganicChemistry,2015,vol.59,p.97-105

[22]ArchivderPharmazie,2015,vol.348,#7,p.475-486

[23]JournalofPhysicalChemistryB,2015,vol.119,#6,p.2475-2489

[24]MedicinalChemistryResearch,2015,vol.24,#12,p.3991-4001

[25]RSCAdvances,2016,vol.6,#18,p.14741-14750

[26]EgyptianJournalofChemistry,2016,vol.59,#6,p.967-984

[27]EgyptianJournalofChemistry,2016,vol.59,#6,p.967-984

[28]ChemistryofHeterocyclicCompounds,2016,vol.52,#11,p.948-951

[29]Khim.Geterotsikl.Soedin.,2016,vol.52,#11,p.948-951,4

[30]InorganicChemistryCommunications,2014,vol.49,p.136-139

[31]Polyhedron,2019,vol.157,p.326-334

[1]Tetrahedron,2007,vol.63,#9,p.1970-1980

[2]ChemicalCommunications,2012,vol.48,#64,p.7982-7984

[3]OrganicLetters,2018,vol.20,#11,p.3187-3191

[4]JournalofMedicinalChemistry,1999,vol.42,#13,p.2441-2446

[5]JournaloftheChemicalSociety,1951,p.485,489,492

[6]JustusLiebigsAnnalenderChemie,1952,vol.575,p.162,167

[7]JournalofMedicinalChemistry,2010,vol.53,#21,p.7664-7674

[8]BioorganicandMedicinalChemistryLetters,2014,vol.24,#13,p.2934-2939

[9]BioorganicandMedicinalChemistry,2015,vol.23,#8,p.1800-1807

[10]JournalofMolecularLiquids,2016,vol.219,p.1058-1064

[11]Chemistry-AEuropeanJournal,2018,vol.24,#48,p.12600-12606

[1]ACSCatalysis,2015,vol.5,#4,p.2062-2069

[1]ACSCatalysis,2017,vol.7,#11,p.7456-7460

[1]CatalysisLetters,2010,vol.137,#1-2,p.63-68

Downstream Synthesis Route

[1]Bioorganicandmedicinalchemistry,2019

[2]Tetrahedron,2007,vol.63,p.1970-1980

[3]ChemicalCommunications,2012,vol.48,p.7982-7984

[4]OrganicLetters,2018,vol.20,p.3187-3191

[5]JournalofMedicinalChemistry,1999,vol.42,p.2441-2446

[6]JournaloftheChemicalSociety,1951,p.485,489,492

[7]JustusLiebigsAnnalenderChemie,1952,vol.575,p.162,167

[8]JournalofMedicinalChemistry,2010,vol.53,p.7664-7674

[9]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.2934-2939

[10]BioorganicandMedicinalChemistry,2015,vol.23,p.1800-1807

[11]JournalofMolecularLiquids,2016,vol.219,p.1058-1064

[12]Chemistry-AEuropeanJournal,2018,vol.24,p.12600-12606

[1]ChemicalandPharmaceuticalBulletin,2007,vol.55,p.115-117

[2]ChineseChemicalLetters,2011,vol.22,p.296-299

[3]EuropeanJournalofMedicinalChemistry,2017,vol.126,p.24-35

[4]EuropeanJournalofMedicinalChemistry,2016,vol.117,p.59-69

[5]AsianJournalofChemistry,2020,vol.32,p.1266-1272

[6]JournaloftheChileanChemicalSociety,2012,vol.57,p.1122-1125,4

[7]JournalofOrganicChemistry,1987,vol.52,p.5009-5015

[8]BioorganicandMedicinalChemistry,2014,vol.22,p.5970-5987

[9]JournalofMedicinalChemistry,1996,vol.39,p.3375-3384

[10]MedicinalChemistryResearch,2017,vol.26,p.3026-3037

[11]EuropeanJournalofMedicinalChemistry,2018,vol.159,p.243-254

[12]JournalofHeterocyclicChemistry,1990,vol.27,p.1177-1180

[13]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.404-408

[14]TurkishJournalofChemistry,2018,vol.42,p.896-907

[15]JournaloftheChineseChemicalSociety,2020,vol.67,p.864-873

[16]AsianJournalofChemistry,2019,vol.31,p.2311-2318

[17]Patent:WO2005/42496,2005,A1.Locationinpatent:Page/Pagecolumn29

[18]MedicinalChemistry,2014,vol.10,p.418-425

[19]ZhurnalObshcheiKhimii,1955,vol.25,p.2138,2140;engl.Ausg.S.2097,2099

[20]JournalofMedicinalChemistry,1999,vol.42,p.381-392

[21]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.409-412

[22]Patent:US5633388,1997,A

[23]MedicinalChemistryResearch,2013,vol.22,p.2840-2846

[24]BioorganicChemistry,2015,vol.59,p.97-105

[25]ArchivderPharmazie,2015,vol.348,p.475-486

[26]JournalofPhysicalChemistryB,2015,vol.119,p.2475-2489

[27]MedicinalChemistryResearch,2015,vol.24,p.3991-4001

[28]RSCAdvances,2016,vol.6,p.14741-14750

[29]EgyptianJournalofChemistry,2016,vol.59,p.967-984

[30]EgyptianJournalofChemistry,2016,vol.59,p.967-984

[31]ChemistryofHeterocyclicCompounds,2016,vol.52,p.948-951    Khim.Geterotsikl.Soedin.,2016,vol.52,p.948-951,4

[32]InorganicChemistryCommunications,2014,vol.49,p.136-139

[33]Polyhedron,2019,vol.157,p.326-334

[34]JournalofComputer-AidedMolecularDesign,2020,vol.34,p.39-54

[1]Pharmazie,1980,vol.35,p.400-401

527-69-5    2963-77-1   
furan-2-carboxylicacid4-(1H-benzimidazol-2-yl)-phenylamide 

[1]EuropeanJournalofMedicinalChemistry,2018,vol.159,p.243-254

[2]IlFarmaco,2003,vol.58,p.1345-1350

2963-77-1    618-46-2   
N-(4-(1H-benzodimidazole-2-yl)phenyl)-3-chlorobenzamide 

[1]EuropeanJournalofMedicinalChemistry,2018,vol.159,p.243-254

[2]IlFarmaco,2003,vol.58,p.1345-1350

Literature

Title: Activation of -N=CH- bond in a Schiff base by divalent nickel monitored by NMR evidence.

Journal: Magnetic resonance in chemistry : MRC 20120501

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives.

Journal: Bioorganic & medicinal chemistry 20100415

Title: Synthesis and Antiulcer Activity Studies of 2-(1'-Iminothioimido Substituted)-1'-Substituted Phenylbenzoic acids.

Journal: Indian journal of pharmaceutical sciences 20080101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Synthesis and antimicrobial activities of some new benzimidazole derivatives.

Journal: Farmaco (Societa chimica italiana : 1989) 20031201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:2963-77-1 Molecular Formula|2963-77-1 MDL|2963-77-1 SMILES|2963-77-1 4-(1H-Benzoimidazol-2-yl)-phenylamine